title: Hypertension management in patients with vascular disease: An update.
abstract: Hypertension (HTN) is a major risk factor for cardiovascular disease. About 80 million U.S. adults (33%) have HTN. Of these individuals, approximately 77% use antihypertensive medication, however, only 54% have controlled HTN. Studies have demonstrated that patients whose blood pressures are controlled achieve a minimum of 50% reduction in cardiovascular events compared to similar patients with poorly controlled blood pressure. This article will define HTN and its consequences. Diagnostic evaluation and evidence-based treatment guidelines for HTN to include lifestyle modifications and pharmacotherapy will be discussed. Finally, this article will examine why the treatment of HTN can prevent the development and reduce the progression of atherosclerosis in vascular disease.
authors: Duke Heart and Vascular, Duke Cardiology, Duke University of Medical Center, Durham, North Carolina. Electronic address: dktrigoboff@yahoo.com.
authors: Debra
authors: D
authors: Kohlman-Trigoboff
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D019983:Guideline Adherence / Q000592:standards*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D008019:Life Style; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents